RHYTHM PHARMACEUTICALS, INC. Earnings Per Share, Basic in USD/shares from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Rhythm Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2019 to Q3 2025.
  • Rhythm Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was -0.82 USD/shares, a 12.3% decline year-over-year.
  • Rhythm Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was -3 USD/shares, a 28.6% increase year-over-year.
  • Rhythm Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2024 was -4.34 USD/shares, a 35.6% decline from 2023.
  • Rhythm Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -3.2 USD/shares, a 7.78% increase from 2022.
  • Rhythm Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -3.47 USD/shares, a 148% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

RHYTHM PHARMACEUTICALS, INC. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$3 -$1 $0 -12.3% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-04
Q2 2025 -$3 -$1 $0 -36.4% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-05
Q1 2025 -$2 -$1 +$1.54 +65.5% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q4 2024 -$4 -$1 $0 -1.43% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-28
Q3 2024 -$4 -$1 +$0.03 +3.95% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-04
Q2 2024 -$4 -$1 +$0.27 +32.9% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-05
Q1 2024 -$4 -$2 -$1 -155% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q4 2023 -$3 -$1 +$0.04 +5.41% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-28
Q3 2023 -$3 -$1 +$0.03 +3.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$3 -$1 +$0.07 +7.87% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$3 -$1 +$0.13 +12.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$3 -$1 +$0.18 +19.6% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-28
Q3 2022 -$3 -$1 $0 -12.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$3 -$1 $0 -27.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 -$3 -$1 -$2 -214% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 -$1 -$1 Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$1 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$1 +$0.01 +1.41% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $0.92 +$1.70 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q2 2020 -$1 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$1 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-03

RHYTHM PHARMACEUTICALS, INC. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$4 -$1 -35.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-28
2023 -$3 +$0.27 +7.78% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-28
2022 -$3 -$2 -148% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-28
2021 -$1 +$1.64 +53.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$3 +$0.82 +21.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$4 Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.